Zoetic Shares Plunge 10.1% After the Sale of DT Ultravert Fell Through

Shares of Zoetic International PLC (LON: ZOE) today fell 10.1% after the company said that it still plans to sell its 75% stake in DT Ultravert after Path Investments failed to meet the long-stop date to complete the deal.

The company said it is still committed to exiting its legacy natural resources business and will continue to have discussions with interested parties including Path Investments.

Zoetic has since repositioned itself to become an industrial hemp and CBD products company with a presence in the UK and North America.

X testing X

WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.

Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.

5.0

Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

The company recently got access to tens of thousands of UK convenience stores via a deal that will see it grow its presence in the country significantly and today’s announcement represents a minor hitch that does not affect its core business.

Trevor Taylor, Zoetic co-CEO said: “We are committed to achieve the best deal possible for our shareholders, and will look at all possible options.”

Zoetic share price

Zoetic shares today fell 10.1% to trade at 62p having retreated from Wednesday’s closing price of 69p.